What is RheumaGen worth?
$37.1Mlast known valuation
RheumaGen last raised $700K in its Seed Round (Apr 2024).
Free account
See the evidence behind this price
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for RheumaGen
Create free account
No card required
Funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Apr 2024 | Seed Round | $700K | ▮ | ▮ |
| Apr 2024 | Seed Round | $4.9M | ▮ | ▮ |
| May 2023 | Seed Round | $300K | ▮ | ▮ |
| Oct 2022 | Seed Round | $2.0M | ▮ | ▮ |
How RheumaGen's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For RheumaGen, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is RheumaGen worth?
- RheumaGen's last known valuation is $37.1M.
- How much has RheumaGen raised?
- RheumaGen has raised $15.3M in total funding across 4 recorded rounds.
- When did RheumaGen last raise?
- RheumaGen last raised in Apr 2024 (Seed Round), raising $700K.